LEUKEMIA - TRIALs: leukemia - List Results - ClinicalTrials.gov

Found 3443 studies with search of: leukemia
Hide studies that are not seeking new volunteers.

1 Active, not recruiting Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia
Conditions: Leukemia; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: decitabine; Drug: vorinostat
Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia - Full Text View - ClinicalTrials.gov


2 Completed CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase
Conditions: Leukemia; Myelodysplastic Syndromes
Intervention: Drug: temsirolimus
CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase - Full Text View - ClinicalTrials.gov


3 Recruiting Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Conditions: Minimal Residual Disease; Leukemia, Lymphoblastic, Acute; Leukemia, Myelogenous, Acute
Interventions: Drug: Clofarabine; Drug: Cytarabine; Drug: Methotrexate
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia - Full Text View - ClinicalTrials.gov


4 Recruiting Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2
Condition: Leukemia
Interventions: Other: flow cytometry; Other: immunologic technique; Other: laboratory biomarker analysis
Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2 - Full Text View - ClinicalTrials.gov


5 Completed Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia
Conditions: Acute Myelogenous Leukemia; Myelodysplasia
Intervention: Biological: autologous tumor cells
Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia - Full Text View - ClinicalTrials.gov


6 Not yet recruiting Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)
Conditions: B-cell Chronic Lymphocytic Leukemia; Hematopoietic/Lymphoid Cancer; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia
Interventions: Drug: carfilzomib;
Other: enzyme-linked immunosorbent assay;
Other: flow cytometry;
Other: pharmacological study;
Genetic: western blotting;
Genetic: reverse transcriptase-polymerse chain reaction; Other: pharmacogenomic studies;
Genetic: mutation analysis;
Genetic: polymorphism analysis; Other: laboratory biomarker analysis
Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) - Full Text View - ClinicalTrials.gov


7 Completed Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia; Lymphoma
Intervention: Biological: apolizumab
Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia - Full Text View - ClinicalTrials.gov


8 Recruiting Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia; CLL
Interventions: Drug: Revlimid, rituximab; Drug: Relapsed or refractory CLL. Lenalidomide and Rituximab
Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) - Full Text View - ClinicalTrials.gov


9 Completed Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia Conditions: Leukemia; Myelodysplastic Syndromes
Intervention: Drug: becatecarin
Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia - Full Text View - ClinicalTrials.gov


10 Active, not recruiting Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Condition: Leukemia
Intervention: Drug: alvocidib
Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia - Full Text View - ClinicalTrials.gov


find the studies here: 3443 studies
Search of: leukemia - List Results - ClinicalTrials.gov